Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Med Mycol ; 55(6): 680-685, 2017 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-27915307

RESUMO

Yeasts of the Cryptococcus species complex are the causative agent of cryptococcosis, especially in human immunodeficiency virus (HIV) positive individuals. Cerebral or disseminated cryptococcosis has a very high mortality rate worldwide, including in Thailand. Additionally, an increasing rate of antifungal drug resistant cryptococcal isolates has been reported in several neighboring countries, complicating therapeutic approaches. To understand the situation of this infection in Thailand, we retrospectively investigated the molecular epidemiology and antifungal drug resistance in a collection of 74 clinical, 52 environmental and two veterinary isolates using the URA5-RFLP for typing and the EUCAST guideline for susceptibility testing. Where no EUCAST breakpoints (AMB and 5FC) were available, CLSI epidemiologic cutoff values were used for interpretation. Cryptococcal molecular type diversity showed most isolates were C. grubii, molecular type VNI. One clinical isolate was C. deuterogattii (mol. type VGII) and another C. grubii (mol. type VNII). One strain from environment was classified as C. grubii (mol. type VNII). No resistant strains were detected in this retrospective study for either of the antimycotics tested; however, monitoring of the epidemiology of Cryptococcus species in infected patients in Thailand needs to be continued to detect emergence of resistance.


Assuntos
Antifúngicos/farmacologia , Criptococose/microbiologia , Cryptococcus/classificação , Cryptococcus/efeitos dos fármacos , Fluconazol/farmacologia , Variação Genética , Análise do Polimorfismo de Comprimento de Fragmentos Amplificados , Animais , Gatos , Columbidae/microbiologia , Criptococose/epidemiologia , Cryptococcus/genética , Cryptococcus/isolamento & purificação , DNA Fúngico/genética , Farmacorresistência Fúngica/efeitos dos fármacos , Microbiologia Ambiental , Fezes/microbiologia , Humanos , Testes de Sensibilidade Microbiana , Epidemiologia Molecular , Técnicas de Tipagem Micológica , Tailândia/epidemiologia
2.
Mycoses ; 58(11): 665-70, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26404188

RESUMO

Cryptococcal meningitis infections cause high mortality rates among HIV-infected patients in Sub-Saharan Africa. The high incidences of cryptococcal infections may be attributed to common environmental sources which, if identified, could lead to institution of appropriate control strategies. To determine the genotypes of Cryptococcus gattii/C. neoformans- species complex from Nairobi, Kenya, 123 clinical and environmental isolates were characterised. Typing was done using orotidine monophosphate pyrophosphorylase (URA5) gene restriction fragment length polymorphism (URA5-RFLP). The majority of the isolates [105/123; 85.4%] were C. neoformans genotype (AFLPI/VNI) and 1.6% AFLP1A/VNB/VNII, whereas (13%) were C. gattii (AFLP4/VGI). This is the first report on the genotypes of C. gattii/C. neoformans species complex from clinical and environmental sources in Nairobi, Kenya and the isolation of C. gattii genotype AFLP4/VGI from the environment in Kenya.


Assuntos
Criptococose/epidemiologia , Cryptococcus gattii/classificação , Cryptococcus gattii/isolamento & purificação , Cryptococcus neoformans/classificação , Cryptococcus neoformans/isolamento & purificação , Animais , Criptococose/microbiologia , Cryptococcus gattii/genética , Cryptococcus neoformans/genética , DNA Fúngico/genética , Microbiologia Ambiental , Genótipo , Humanos , Quênia/epidemiologia , Técnicas de Tipagem Micológica , Reação em Cadeia da Polimerase , Polimorfismo de Fragmento de Restrição
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA